Can SGLT-2 inhibitors improve cardiovascular outcomes and ensure safety for patients with type 2 diabetes and heart failure in Thailand? A real-world multicentre retrospective cohort study
SGLT-2抑制剂能否改善泰国2型糖尿病合并心力衰竭患者的心血管结局并确保其安全性?一项真实世界多中心回顾性队列研究
期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-090226
Kongmalai, Tanawan; Tansawet, Amarit; Pattanaprateep, Oraluck; Ratanatharathorn, Cholatid; Amornritvanich, Porntep; Looareesuwan, Panu; Boonwatcharapai, Burin; Khunakorncharatphong, Anon; Nimitphong, Hataikarn; Srinonprasert, Varalak; Thakkinstian, Ammarin